Azitra Inc
Azitra Inc is listed today as Azitra, Inc.: market value, financials and filings are on its company page.
Funding rounds
5 counted as startup funding. Open the number of investors for the round's details.
| Month | Raised | Raise | Size | Investors | Sold | Filing |
|---|---|---|---|---|---|---|
| Jan 2021 | $1 M | No. 5 | Under $2 million | equity, debt, options | SEC | |
| Sep 2020 | $17 M | No. 4 | $10 to $50 million | equity | SEC | |
| Feb 2019 | $5 M | No. 3 | $2 to $10 million | equity, options | SEC | |
| Apr 2018 | $2 M | No. 2 | $2 to $10 million | debt, options | SEC | |
| Mar 2017 | $3 M | No. 1 | $2 to $10 million | equity | SEC |
Source: SEC Form D. Each row is one private sale of securities with the running total of its newest notice. The form does not name the series or the investors; rounds are numbered in the order they were filed. A round's details show what its notice does say: accredited and other investors, the smallest investment taken, the exemption claimed, fees, the people named and the brokers paid to sell it.
How it makes money#
What its filings and its own website say, sentence by sentence, each with its source.
Azitra Inc chose not to state its revenue in its newest notice of a funding round (Jan 2021).
SEC Form D · Jan 2021
The industry group it chose in its notices: Biotechnology.
SEC Form D · Jan 2021
That is all the official record says: Azitra Inc has not published its revenue in a filing we can read, and no other official source covers it. Revenue figures come from crowdfunding filings (SEC Form C) and from annual reports once a company is listed.
Products and services#
No products or services of Azitra Inc are on record.
Investors#
19 named in official filings. Open an investor to see everything it has backed.
| Investor | Kind | Amount | Round | Role | Source |
|---|---|---|---|---|---|
| Bayer Healthcare LLC | Other | not stated | not stated | Held Series B preferred stock, 10% owner (Form 3, 2023) | SEC Form 3 |
| Bayer US Holding LP | Fund or asset manager | not stated | not stated | Held Series B preferred stock, 10% owner (Form 3, 2023) | SEC Form 3 |
| Bayer World Investments B.V. | Fund or asset manager | not stated | not stated | Held Series B preferred stock, 10% owner (Form 3, 2023) | SEC Form 3 |
| BIOS Advisors GP, LLC | Fund or asset manager | not stated | not stated | Held Series A, A-1 and B preferred stock, 10% owner (Form 3, 2023) | SEC Form 3 |
| BIOS Azitra Co-Invest I, LP | Fund or asset manager | not stated | not stated | Held Series A, A-1 and B preferred stock, 10% owner (Form 3, 2023) | SEC Form 3 |
| BIOS Capital Management, LP | Fund or asset manager | not stated | not stated | Held Series A, A-1 and B preferred stock, 10% owner (Form 3, 2023) | SEC Form 3 |
| BIOS Equity Partners III, LP | Private equity | not stated | not stated | Held Series A, A-1 and B preferred stock, 10% owner (Form 3, 2023) | SEC Form 3 |
| Bios Equity Partners II, LP | Private equity | not stated | not stated | Held Series A, A-1 and B preferred stock, 10% owner (Form 3, 2023) | SEC Form 3 |
| Bios Equity Partners, LP | Private equity | not stated | not stated | Held Series A, A-1 and B preferred stock, 10% owner (Form 3, 2023) | SEC Form 3 |
| BIOS Fund III, LP | Fund or asset manager | not stated | not stated | Held Series A, A-1 and B preferred stock, 10% owner (Form 3, 2023) | SEC Form 3 |
| BIOS Fund III NT, LP | Fund or asset manager | not stated | not stated | Held Series A, A-1 and B preferred stock, 10% owner (Form 3, 2023) | SEC Form 3 |
| BIOS Fund III QP, LP | Fund or asset manager | not stated | not stated | Held Series A, A-1 and B preferred stock, 10% owner (Form 3, 2023) | SEC Form 3 |
| BIOS Fund II, LP | Fund or asset manager | not stated | not stated | Held Series A, A-1 and B preferred stock, 10% owner (Form 3, 2023) | SEC Form 3 |
| BIOS Fund II NT, LP | Fund or asset manager | not stated | not stated | Held Series A, A-1 and B preferred stock, 10% owner (Form 3, 2023) | SEC Form 3 |
| BIOS Fund II QP, LP | Fund or asset manager | not stated | not stated | Held Series A, A-1 and B preferred stock, 10% owner (Form 3, 2023) | SEC Form 3 |
| BIOS Fund I, LP | Fund or asset manager | not stated | not stated | Held Series A, A-1 and B preferred stock, 10% owner (Form 3, 2023) | SEC Form 3 |
| BIOS Fund I QP, LP | Fund or asset manager | not stated | not stated | Held Series A, A-1 and B preferred stock, 10% owner (Form 3, 2023) | SEC Form 3 |
| Cavu Advisors, LLC | Fund or asset manager | not stated | not stated | Held Series A, A-1 and B preferred stock, 10% owner (Form 3, 2023) | SEC Form 3 |
| Cavu Management, LP | Fund or asset manager | not stated | not stated | Held Series A, A-1 and B preferred stock, 10% owner (Form 3, 2023) | SEC Form 3 |
Source: SEC Form 3 statements, SEC Form N-PORT fund reports, Wikidata, value.today research. Names come from filings that do name holders: the preferred stock each holder had when the company registered its shares (Form 3), private shares in US mutual funds' portfolio reports (N-PORT), and Wikidata. None ties a name to one funding round, so this list is per company, and it is not complete: the 5 rounds above had up to 8 investors.
Largest shareholders today
Institutions holding Azitra, Inc. shares, as of Sep 30, 2026.
- Dauntless Investment Group, LLC$2 M—
- Stonepine Capital Management, LLC$1 M—
- Nantahala Capital Management, LLC$0 M—
- Vanguard Fiduciary Trust Co$0 M—
- Susquehanna International Group, LLP$0 M—
- Jane Street Group, LLC$0 M—
- HRT Financial LP$0 M—
- Geode Capital Management, LLC$0 M—
- StoneX Group Inc.$0 M—
- Virtu Financial LLC$0 M—
- Tower Research Capital LLC (TRC)$0 M—
- UBS Group AG$0 M—
- Two Sigma Securities, LLC$0 M—
- Flow Traders U.S. LLC$0 M—
- Corient Private Wealth LP$0 M—
Source: SEC Form 13F holdings reports · as of Sep 30, 2026. Value held and share of the company. All holders are on the company page.
Executives and directors
As the company named them in its notices. Directors of a funded startup are often partners of its investors.
| Name | Role | Named in |
|---|---|---|
| Richard Andrews | Executive officer | Jan 2021 |
| Ricahrd Andrews | Executive officer | Sep 2020 |
| Travis Whitfill | Executive officer | Apr 2018 |
| Azim Munivar | Executive officer | Mar 2017 |
| Andrew McClary | Director | Jan 2021 |
| Lucio Iannone | Director | Jan 2021 |
| Richard Andrews | Director | Jan 2021 |
| Stella Robertson | Director | Jan 2021 |
| Travis Whitfill | Director | Jan 2021 |
| Cain McClary | Director | Sep 2020 |
| Ricahrd Andrews | Director | Sep 2020 |
| Azim Munivar | Director | Apr 2018 |
| Daniel Wagner | Director | Apr 2018 |
| Richard Andrews | Promoter | Apr 2018 |
| Azim Munivar | Promoter | Mar 2017 |
| Travis Whitfill | Promoter | Mar 2017 |
Went public since 2023. Its SEC number is that of a company listed on a stock exchange.